Chemoinformaics analysis of 2-PROP-1-ENYL-P-CYMENE
Molecular Weight | 174.287 | nRot | 2 |
Heavy Atom Molecular Weight | 156.143 | nRig | 7 |
Exact Molecular Weight | 174.141 | nRing | 1 |
Solubility: LogS | -4.846 | nHRing | 0 |
Solubility: LogP | 4.791 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 0 | APOL | 33.7123 |
nHD | 0 | BPOL | 18.0577 |
QED | 0.631 |
Synth | 2.194 |
Natural Product Likeliness | -0.034 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.666 |
Pgp-sub | 0.028 |
HIA | 0.005 |
CACO-2 | -4.62 |
MDCK | 0.000019 |
BBB | 0.519 |
PPB | 0.970599 |
VDSS | 3.169 |
FU | 0.0342955 |
CYP1A2-inh | 0.904 |
CYP1A2-sub | 0.951 |
CYP2c19-inh | 0.735 |
CYP2c19-sub | 0.905 |
CYP2c9-inh | 0.515 |
CYP2c9-sub | 0.853 |
CYP2d6-inh | 0.735 |
CYP2d6-sub | 0.925 |
CYP3a4-inh | 0.185 |
CYP3a4-sub | 0.56 |
CL | 7.956 |
T12 | 0.211 |
hERG | 0.038 |
Ames | 0.018 |
ROA | 0.022 |
SkinSen | 0.829 |
Carcinogencity | 0.206 |
EI | 0.992 |
Respiratory | 0.043 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.663682 |